U.S. CDMRP – Duchenne Muscular Dystrophy Research Program (DMDRP) | Research Funding


Event details

Date 01.08.2024
Category Call for proposal

Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2024 Duchenne Muscular Dystrophy Research Program (DMDRP). Several award programs are available:

  • The Clinical/Translational Research Award supports advanced translational research that will accelerate the movement of promising ideas in DMD research into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. However, applicants should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between applied and clinical research. As such, applications must include preliminary and/or published data relevant to DMD to support the proposed research project.
All applications must specifically address at least one of the Focus Areas listed in this document.
  • The Idea Development Award promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with DMD. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.
All applications must specifically address at least one of the Focus Areas listed in this document.

  • Clinical/Translational Research Award: $650,000 – 1.5M
  • Idea Development Award: $350,000

  • Clinical/Translational Research Award: 3-4  years
  • Idea Development Award: 2 years

Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.

How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.

Pre-Application Deadline:           01 August 2024, 5:00 p.m. Eastern time
Full Application Deadline:          22 August 2024, 11:59 p.m Eastern Time

Further information:
  • To find the full program announcements and to start your pre-application see here
  • A useful summary of each call can be found here
  • For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
  • Grants.gov Funding Opportunity Numbers:

Practical information

  • General public
  • Free


Event broadcasted in